Keystone Financial Planning Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$14.1M |
| 2 |
International Flavors & Fragrances
IFF
|
+$6.92M |
| 3 |
Colgate-Palmolive
CL
|
+$687K |
| 4 |
Pfizer
PFE
|
+$554K |
| 5 |
ExxonMobil
XOM
|
+$351K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$7.65M |
| 2 |
Unilever
UL
|
+$6.56M |
| 3 |
K
Kellanova
K
|
+$1.47M |
| 4 |
Medtronic
MDT
|
+$867K |
| 5 |
Pinnacle West Capital
PNW
|
+$55.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 8.76% |
| 2 | Technology | 8.08% |
| 3 | Healthcare | 7.63% |
| 4 | Utilities | 7.47% |
| 5 | Industrials | 5.44% |
Similar funds
Keystone Financial Planning's Q2 2023 Portfolio in Review
As of Q2 2023, Keystone Financial Planning held 49 positions worth $299M, up 1.6% from $294M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Keystone Financial Planning deployed $9.33M of net new capital in Q2 2023, opening 4 new positions and adding to 33 existing holdings. Its largest new stake was Colgate-Palmolive: 8,875 shares worth $684K.
By sector, the portfolio is most concentrated in Consumer Staples at 8.8% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was GSK, an estimated $7.65M trimmed.
- Keystone Financial Planning's largest Q2 2023 buy was Colgate-Palmolive: 8,875 shares worth $684K.
- Keystone Financial Planning added most to Schwab US Dividend Equity ETF in Q2 2023, an estimated $14.1M increase.
- Keystone Financial Planning's biggest Q2 2023 reduction was GSK, cutting an estimated $7.65M.
- Keystone Financial Planning fully exited Kellanova in Q2 2023, selling an estimated $1.47M.
- Keystone Financial Planning's ten largest holdings make up 65% of its $299M portfolio in Q2 2023.
- Keystone Financial Planning opened 4 new positions and closed 2 in Q2 2023.
- Keystone Financial Planning's portfolio value rose 1.6% quarter-over-quarter to $299M.
Based on Keystone Financial Planning's 13F filing for Q2 2023, filed 11 Jul 2023.